343 results on '"D'Addio, Francesca"'
Search Results
2. Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule
3. Physical Activity and Inflammation
4. Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide
5. Daytime hypoglycemic episodes during the use of an advanced hybrid closed loop system
6. Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease
7. eATP and autoimmune diabetes
8. Abnormalities of the oculomotor function in type 1 diabetes and diabetic neuropathy
9. Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE study
10. Prevalence and significance of mesentery thickening and lymph nodes enlargement in Crohn's disease
11. The IGFBP3/TMEM219 pathway regulates beta cell homeostasis
12. Next-gen therapeutics to spare and expand beta-cell mass
13. TMEM219 regulates the transcription factor expression and proliferation of beta cells
14. miR-21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy
15. Strictureplasties performed by laparoscopic approach for complicated Crohn's disease. A prospective, observational, cohort study
16. The IL-8-CXCR1/2 axis contributes to diabetic kidney disease
17. Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis
18. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection
19. Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide
20. Novel Soluble Mediators of Innate Immune System Activation in Solid Allograft Rejection
21. Embryonic stem cell extracts improve wound healing in diabetic mice
22. The β-cell effect of verapamil-based treatment in patients with type 2 diabetes: a systematic review
23. TMEM219 regulates the transcription factor expression and proliferation of beta cells.
24. The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysis
25. Chapter 31 - Autoimmune (Type 1) diabetes
26. Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19”
27. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes
28. GLP1R Strives T Cell Negative Costimulation Through a rRNA Gene Repressor Interactome
29. Type 1 Diabetes and Dysfunctional Intestinal Homeostasis
30. PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes
31. Immunotherapy for type 1 diabetes
32. Immunoevasion rather than intrinsic oncogenicity may confer MSCs from non-obese diabetic mice the ability to generate neural tumors
33. Response to Comment on D’Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800–1806
34. Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes
35. The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists
36. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes
37. Inflammation and vascular dysfunction: The negative synergistic combination of diabetes and COVID‐19
38. Targeting a novel apoptotic pathway in human disease.
39. Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site
40. Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets
41. Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets
42. B7h (ICOS-L) Maintains Tolerance at the Fetomaternal Interface
43. Harnessing the immunological properties of stem cells as a therapeutic option for diabetic nephropathy
44. Positive effects of a novel non-peptidyl low molecular weight radical scavenger in renal ischemia/reperfusion: a preliminary report
45. List of contributors
46. Targeting Tim-1 to Overcome Resistance to Transplantation Tolerance Mediated by CD8 T17 Cells
47. PD-1 blockade counteracts post–COVID-19 immune abnormalities and stimulates the anti–SARS-CoV-2 immune response
48. Anti-diabetic drugs and weight loss in patients with type 2 diabetes
49. Hematopoietic Stem Cells in Type 1 Diabetes
50. The rise, fall, and resurgence of immunotherapy in type 1 diabetes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.